methanesulfonyl fluoride
Small moleculeexperimental
Clinical trial activity
1 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Dec 1, 2009 (NCT01269476)
Timeline
2000s
- Jan 1, 2009
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- AcetylcholinesteraseINHIBITOR
ACHE inhibitor
Chemistry & pharmacology
Loading structure…
SMILES
CS(=O)(=O)F- Mol. weight
- 98.1 g/mol
- Lipinski Ro5
- Pass
- Rule of 3
- Yes
- Chirality
- Achiral Molecule
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL4297433 ↗
Also known as
- methanesulfonyl fluoride
- methanesulfonyl fluoride
- msf
- snx-001
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01269476 | Phase 1 | Dec 1, 2009 | Scope Life Sciences GmbH, SeneXta Therapeutics SA |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Scope Life Sciences GmbH | For profit | 1 | 0 | 1 | 2009 |
| SeneXta Therapeutics SA | For profit | 1 | 1 | 1 | 2009 |
2 organizations
Page 1 / 1